CDK19/CycC Recombinant Human Active Protein Kinase
CDK19 is a kinase that controls the dynamic transcription of specific genes in response to various signals. CDK19 is hijacked by various solid and liquid tumors to maintain excessive cell proliferation. CDK19/CycC Recombinant Human Active Protein Kinase is an ortholog of CDK19[1].
Product Specifications
UNSPSC
12352211
Target
CDK
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer
Smiles
[CDK19/CycCRecombinantHumanActiveProteinKinase]
References & Citations
[1]Xu J, et al. Discovery of a Novel and Potent Cyclin-Dependent Kinase 8/19 (CDK8/19) Inhibitor for the Treatment of Cancer. J Med Chem. 2024 May 23;67 (10) :8161-8171.
Shipping Conditions
Room temperature
Scientific Category
Enzyme
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rabbit Polyclonal SIN3A Antibody [FITC]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
033470-AP 200 µL
CD1C, CT (CD1C, T-cell surface glycoprotein CD1c, CD1c) (AP) discontinued
Ask
View Details 
